🔎 Trials Near Me

Home › Cancer (all types) › Connecticut › New Haven

Cancer (all types) clinical trials in New Haven, CT

34 studies for Cancer (all types) are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of ASP3082 in Adults With Advanced Solid Tumors

RecruitingPhase 1
  • Smilow Cancer Center at Yale New Haven Hospital, New Haven
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05382559

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

RecruitingPhase 1
  • Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07578571

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

RecruitingPhase 3
  • Yale University, New Haven
  • Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi away
  • Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi away
  • and 1 more
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05256225

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

RecruitingPhase 3
  • Yale University School of Medicine, New Haven
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06901531

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

RecruitingPhase 2/3
  • Yale Cancer Center, New Haven
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

RecruitingPhase 1/2
  • Yale New Haven Hospital ( Site 3012), New Haven
1 Month – 17 Years · All sexes · Updated Sep 17, 2026 · NCT06941272

Statins to Prevent Cancer Associated Blood Clots

RecruitingPhase 4
  • Yale University, New Haven
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07303816

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

RecruitingPhase 2
  • West Haven VA Medical Center, West Haven · 3 mi away
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

RecruitingPhase 1/2
  • Smilow Cancer Center At Yale-New Haven /ID# 272447, New Haven
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06953960

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RecruitingPhase 3
  • Yale University School of Medicine, New Haven
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

RecruitingPhase 3
  • Smilow Cancer Hospital at Yale New Haven, New Haven
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612

Unified Network for Integrated Fluid Collection at Yale

RecruitingObservational study
  • Smilow Cancer Hospital, New Haven
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07689864

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Yale University, New Haven
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • Yale University School of Medicine, New Haven
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

RecruitingPhase 1
  • Yale- New Haven Hospital- Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06759649

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven
  • Yale University, New Haven
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314

A Study of ASP1002 in Adults for Treatment of Solid Tumors

RecruitingPhase 1
  • Yale University Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05719558

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • Yale University, Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Recruiting
  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 3 mi away
Ages 18 to 75 · All sexes · Updated Jun 17, 2026 · NCT05486572

Evaluation of a Mobile App Program for Coping With Cancer

Recruiting
  • Smilow Cancer Hospital, New Haven
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT06923501

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Recruiting
  • Yale New Haven Health Smilow York Street Hospital, New Haven
Ages 5 and older · All sexes · Updated Jun 12, 2026 · NCT07019259

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

RecruitingPhase 1
  • Yale University School of Medicine /ID# 225707, New Haven
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT04777994

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

RecruitingPhase 1
  • GSK Investigational Site, New Haven
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06551142

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

RecruitingPhase 2
  • Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

RecruitingObservational studyHealthy volunteers welcome
  • Yale University, New Haven
Ages 50 and older · All sexes · Updated Apr 13, 2026 · NCT03937453

Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

Recruiting
  • Pediatric Hematology/Oncology Clinic in Smilow Cancer Hospital, New Haven
Ages 13 to 39 · All sexes · Updated Feb 25, 2026 · NCT07224204

A Study of YL242 in Subjects With Advanced Solid Tumors

RecruitingPhase 1/2
  • US-201, New Haven
Ages 18 and older · All sexes · Updated Dec 24, 2025 · NCT07197827

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

RecruitingPhase 1
  • Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT05808634

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

RecruitingObservational study
  • Yale University - Cancer Center, New Haven
All ages · All sexes · Updated Aug 15, 2025 · NCT05406167

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

RecruitingPhase 1/2
  • Yale University, New Haven
Ages 18 and older · All sexes · Updated Feb 13, 2025 · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Recruiting
  • Yale University, New Haven
  • Smilow Hospital Care Center, Guilford, Guilford · 13 mi away
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

RecruitingPhase 1/2
  • Yale Cancer Center, New Haven
Ages 18 and older · All sexes · Updated Nov 15, 2024 · NCT04787042

About Cancer (all types)

If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.

More about Cancer (all types) on MedlinePlus

Cancer (all types) trials in other cities

Other studies in New Haven

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.